Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Wayde, Karla crowned as KovsieSport’s best
2015-10-21

 

The pride of KovsieSport. From the left, are: Ox Nche
(UFS Junior Sportman of the Year), Karla Mostert
(Senior Sportswoman of the Year), Wayde van Niekerk
(Senior Sportsman of the Year), and Brett Walraven
(on behalf of his sister, Nicole Walraven – Junior Sportswoman of the Year).
Photo: Hannes Naude

The journey does not belong to him alone, but to everyone at KovsieSport.

These were the words of University of the Free State’s (UFS) Wayde van Niekerk, after being named as KovsieSport’s Senior Sportsman of the Year on Wednesday 21 October 2015.

The South African sports star walked away with the award for the third consecutive year, while the Protea netball defender, Karla Mostert, was crowned Senior Sportswoman for the first time.

The Junior Bok, Ox Nche, and the Protea hockey player, Nicole Walraven, were named as Junior Sportsman and Junior Sportswoman of the Year respectively.

Nche represented South Africa’s U20 rugby team this year at the Junior World Championships, played for the Shimlas, and was named the UFS Rugby Club’s best junior player.

Walraven made her debut for South Africa in 2015. She was crowned jointly as the best player at the Provincial U21 tournament, and was also Hockey South Africa’s U21 Player of the Year.

Van Niekerk won gold in the 400 metres at the World Championships in Beijing, becoming only the fourth athlete in history to run the 400 m in less than 44 seconds, and the 200 metres in less than 20 seconds.

“This is precious, and something I will cherish as an athlete: being part of KovsieSport,” he said.

“I arrived at the UFS as a high school boy, started as a junior, and was accepted immediately.”

“I really appreciate everybody who played such a huge part in my life.”

Mostert was named as Player of the Series in the Brutal Fruit series, as well as the Varsity series this year. She was also a star for the Proteas at the World Cup.

“This (the award) is definitely a good way to end my time at Kovsies. This is something one is trying to achieve for years, so it really is a highlight.”

She said it was difficult to describe how much KovsieSport is doing for its athletes, and this was the reason why the UFS achieves so many successes in sport.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept